MULTIPLE MYELOMA IN RELAPSE
Clinical trials for MULTIPLE MYELOMA IN RELAPSE explained in plain language.
Never miss a new study
Get alerted when new MULTIPLE MYELOMA IN RELAPSE trials appear
Sign up with your email to follow new studies for MULTIPLE MYELOMA IN RELAPSE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New CAR T-Cell therapy aims to control Hard-to-Treat multiple myeloma
Disease control Not yet recruitingThis early-stage study tests a new treatment called S103 for people with multiple myeloma that has returned or stopped responding to standard therapies. S103 uses a patient's own immune cells, modified to target and attack the cancer. The main goals are to check safety and find t…
Matched conditions: MULTIPLE MYELOMA IN RELAPSE
Phase: PHASE1, PHASE2 • Sponsor: Hebei Senlang Biotechnology Inc., Ltd. • Aim: Disease control
Last updated May 26, 2026 06:16 UTC
-
Can a booster shot make CAR-T last longer in myeloma?
Disease control Not yet recruitingThis study tests whether adding a drug called NT-I7 (IL-7) after standard CAR-T therapy can help the immune cells stay active longer and control multiple myeloma better. About 52 adults whose myeloma has returned or not responded to treatment will receive either NT-I7 or a placeb…
Matched conditions: MULTIPLE MYELOMA IN RELAPSE
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 26, 2026 04:37 UTC
-
Curcumin gets a makeover: new liposomal form tested in blood cancer
Disease control Not yet recruitingThis early-phase study tests the safety of a new form of curcumin (liposomal curcumin) in people with multiple myeloma that has returned or stopped responding to treatment. About 20 participants will receive the drug, with doses increasing in later groups to find the highest safe…
Matched conditions: MULTIPLE MYELOMA IN RELAPSE
Phase: PHASE1 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
Home injection trial could free myeloma patients from hospital visits
Symptom relief Not yet recruitingThis study looks at whether people with multiple myeloma can safely give themselves the drug daratumumab at home instead of going to the hospital. About 50 patients will alternate between home and clinic doses to compare feasibility and safety. The goal is to make treatment more …
Matched conditions: MULTIPLE MYELOMA IN RELAPSE
Phase: PHASE4 • Sponsor: Odense University Hospital • Aim: Symptom relief
Last updated May 26, 2026 06:25 UTC